Study: Antidepressant Paxil Is Not Safe for Teens

Advertisement

A reanalysis of a study claims that Paxil, an antidepressant made by GlaxoSmithKline (GSK), isn’t safe for teens.

paxil-teens-gsk
Source: iStockphoto

Researchers were allowed to look over a study of Paxil published in 2001 and found that the drug could have adverse effects on teens. The data from the study was the same that was used to give the drug approval from the U.S. Food and Drug Administration (FDA), reports The New York Times.

A new team of researchers looked over the full data from the study, which was provided to them by GlaxoSmithKline, and found that it had little to no effect in helping depression in teens. This group also found that several incidents of attempted suicide were made by teens taking the drug, but that they were listed as “emotional lability,” NYT notes.

Jon Jureidini, a professor at the University of Adelaide in Australia, led the team that conducted the reanalysis of the Paxil study. He claims that it’s “hard to think there wasn’t some mischief being done,” and that there were efforts to devalue the adverse effects of the antidepressant, reports The Washington Post.

More From InvestorPlace:
Is the Under Armour Stock Split a Raw Deal for UA Owners?
Grab These 1% Stocks while They Are Cheap
5 Boom or Bust Energy Stocks to Buy


Article printed from InvestorPlace Media, https://investorplace.com/2015/09/paxil-teens-gsk/.

©2024 InvestorPlace Media, LLC